Watch video. New data show ritlecitinib plus phototherapy beneficial for nonsegmental vitiligo In patients with active nonsegmental vitiligo, ritlecitinib (Litfulo, Pfizer) monotherapy or paired ...
Pfizer meanwhile is also testing ritlecitinib for vitiligo, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 ...
Pfizer, meanwhile, is also testing ritlecitinib for vitiligo, rheumatoid arthritis, Crohn's disease, and ulcerative colitis. A US district court has granted an injunction sought by Incyte on the ...
Ritlecitinib, provided under the brand name Litfulo, had previously been approved in England. It is for treating severe alopecia areata in people who are aged 12 and over. Last month Megan ...